Advertisement

Topics

Data at SABCS and ASH Demonstrate Daiichi Sankyo Commitment to Advancing Science in Breast and Blood Cancer

08:02 EST 14 Nov 2017 | FinanzNachrichten

- Updated DS-8201 data in HER2-positive metastatic breast cancer as well as HER2 low-expressing breast cancer to be highlighted at SABCS - Preliminary phase 1 data on DS-3201, a dual EZH1/2 inhibi...

Original Article: Data at SABCS and ASH Demonstrate Daiichi Sankyo Commitment to Advancing Science in Breast and Blood Cancer

NEXT ARTICLE

More From BioPortfolio on "Data at SABCS and ASH Demonstrate Daiichi Sankyo Commitment to Advancing Science in Breast and Blood Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...